$Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab$
Cover image not available

Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab

National Institute for Health and Clinical Excellence

Publication Data

Title Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2010
Publication location London
Language English

Descriptive Notes

Issue date: October 2010.
"This guidance was developed using the single technology appraisal process."

Topics

Chronic lymphocytic leukemia :: Chemotherapy :: England
Chronic lymphocytic leukemia :: Chemotherapy :: Wales
Monoclonal antibodies

Catalogue Data

OBNB ID GBB586370
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99419061

ISBD

P1053 1 online resource (42 pages).
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2010. Publication and catalogue information, links to buy online and reader comments.